COMPANY OVERVIEW
-
Main Products
API,Pembrolizumab,semaglutide
-
Payment Terms
L/C,100% TT in advance
-
Business Type
Trader -
Location
Jiangsu, China -
Year Established
2023 -
Total Employees
5-10 -
Total Annual Revenue
$1 million-$2.5 million
HOT PRODUCTS
Trastuzumab 180288-69-1
Get Price180288-69-1
/
98%
/
/
1G/bottle
Send an Inquiry